Skip to main content

Advertisement

SpringerLink
Log in

New insights in diagnosis and treatment for Retinopathy of Prematurity

  • Review
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

The purpose of this study was to review current perspectives on diagnosis and treatment of Retinopathy of Prematurity (ROP). We performed a systematic review of how much has been produced in research published online and on print regarding ROP in different settings around the world. Early Treatment for ROP (ETROP) classification is the currently accepted classification of ROP. Fluorescein angiography and spectral domain optical coherence tomography (SD-OCT) may eventually lead to changes in the definition of ROP, and as a consequence, they will serve as a guide for treatment. Intravitreal anti-VEGF therapy has proven to be more effective in terms of lowering recurrence, allowing growth of the peripheral retina, and diminishing the incidence of retinal detachment when proliferative ROP is diagnosed. Whether anti-VEGF plus laser are better than any of these therapies separately remains a subject of discussion. Telemedicine is evolving everyday to allow access to remote areas that do not count with a retina specialist for treatment. A management algorithm is proposed according to our reference center experience. ROP is an evolving subject, with a vulnerable population of study that, once treated with good results, leads to a reduction in visual disability and in consequence, in a lifetime improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. International Committee for the Classification of Retinopathy of Prematurity (2005) The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 123(7):991–999

    Article  Google Scholar 

  2. iVue Product Website. http://optovue.somethumb.net/products/ivue/ Accessed 1 October 2015

  3. Klufas MA, Patel SN, Ryan MC et al (2015) Influence of fluorescein angiography on the diagnosis and management of retinopathy of prematurity. Ophthalmology 122(8):1601–1608

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gschliesser A, Stifter E, Neumayer T et al (2015) Inter-expert and Intra-expert Agreement on the Diagnosis and Treatment of Retinopathy of Prematurity. Am J Ophthalmol 160(3):553e3–560e3

    Article  Google Scholar 

  5. Patel SN, Klufas MA, Ryan MC et al (2015) Color fundus photography versus fluorescein angiography in identification of the macular center and zone in retinopathy of prematurity. Am J Ophthalmol 159(5):950e2–957e2

    Article  Google Scholar 

  6. Ng EY, Lanigan B, O’Keefe M (2006) Fundus fluorescein angiography in the screening for and management of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 43(2):85–90

    PubMed  Google Scholar 

  7. Yokoi T, Hiraoka M, Miyamoto M et al (2009) Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography. Ophthalmology 116(7):1377–1382

    Article  PubMed  Google Scholar 

  8. Henaine-Berra A, Garcia-Aguirre G, Quiroz-Mercado H, Martinez-Castellanos MA (2014) Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy. J AAPOS 18(2):120–123

    Article  PubMed  Google Scholar 

  9. Alba-Orozco A, Rodríguez-Quiñones L, Sepúlveda H, Morales-Canton V, Martínez-Castellanos MA. Fluorescein Angiography Differences Between Retinopathy of Prematurity and Retinopathy Induced by Oxygen in Preterm Newborns. ARVO 2014 Anual Meeting Abstracts

  10. Vajzovic L, Hendrickson AE, O’Connell RV, et al. (2012) Maturation of the human fovea: correlation of spectral-domain optical coherence tomography findings with histology. Am J Ophthalmol. 154(5):779–89 e2

  11. Cernichiaro-Espinosa LA, Garcia-Huerta MM, Giordano VE et al (2014) Comparison of iridocorneal angle in infants with retinopathy of prematurity and healthy infants using spectral domain optical coherence tomography. J AAPOS 18(4):344–346

    Article  PubMed  Google Scholar 

  12. Vinekar A, Avadhani K, Sivakumar M, et al. (2012) Macular edema in premature infants. Ophthalmology. 119(6):1288-9 e1; author reply 9-90 e1

  13. Vinekar A, Avadhani K, Sivakumar M et al (2011) Understanding clinically undetected macular changes in early retinopathy of prematurity on spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 52(8):5183–5188

    Article  PubMed  Google Scholar 

  14. Vinekar A, Mangalesh S, Jayadev C et al (2015) Macular edema in Asian Indian premature infants with retinopathy of prematurity: impact on visual acuity and refractive status after 1-year. Indian J Ophthalmol 63(5):432–437

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wu WC, Shih CP, Wang NK et al (2013) Choroidal thickness in patients with a history of retinopathy of prematurity. JAMA Ophthalmol 131(11):1451–1458

    Article  PubMed  Google Scholar 

  16. Erol MK, Ozdemir O, Turgut Coban D et al (2014) Macular findings obtained by spectral domain optical coherence tomography in retinopathy of prematurity. J Ophthalmol 2014:468653

    Article  PubMed  PubMed Central  Google Scholar 

  17. Cryotherapy for Retinopathy of Prematurity Cooperative Group (1988) Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol 106(4):471–479

    Article  Google Scholar 

  18. Cryotherapy for Retinopathy of Prematurity Cooperative Group (2001) Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol 119(8):1110–1118

    Article  Google Scholar 

  19. STOP-ROP Multicenter Study Group (2000) Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 105(2):295–310

    Article  Google Scholar 

  20. Reynolds JD, Hardy RJ, Kennedy KA, Spencer R, van Heuven WA, Fielder ARs, Light reduction in retinopathy of prematurity (LIGHT-ROP) Cooperative Group (1998) Lack of efficacy of light reduction in preventing retinopathy of prematurity. N Engl J Med 338(22):1572–1576

    Article  CAS  PubMed  Google Scholar 

  21. Good WV, Early Treatment for Retinopathy of Prematurity Cooperative G (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 102: 233–248; discussion 48-50

  22. Early Treatment For Retinopathy of Prematurity Cooperative Group (2003) Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121(12):1684–1694

    Article  CAS  PubMed  Google Scholar 

  23. Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Group B-RC. Efficacy of intravitreal bevacizumab for stage 3 + retinopathy of prematurity. N Engl J Med 364(7):603–615

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pertl L, Steinwender G, Mayer C et al (2015) A systematic review and meta-analysis on the safety of vascular endothelial growth factor (VEGF) inhibitors for the treatment of retinopathy of prematurity. PLoS ONE 10(6):e0129383

    Article  PubMed  PubMed Central  Google Scholar 

  25. Vinekar A, Jayadev C, Mangalesh S et al (2015) Comparing the outcome of single versus multiple session laser photoablation of flat neovascularization in zone 1 aggressive posterior retinopathy of prematurity: a prospective randomized study. Retina 35(10):2130–2136

    Article  PubMed  Google Scholar 

  26. Kim J, Kim SJ, Chang YS, Park WS (2014) Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity. Retina 34(1):77–82

    Article  CAS  PubMed  Google Scholar 

  27. Castellanos MA, Schwartz S, Garcia-Aguirre G, Quiroz-Mercado H (2013) Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity. Br J Ophthalmol 97(7):816–819

    Article  PubMed  Google Scholar 

  28. Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML, Salazar-Teran N, Chan RV (2008) Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 28(3 Suppl):S19–S25

    Article  PubMed  Google Scholar 

  29. Salman AG, Said AM (2015) Structural, visual and refractive outcomes of intravitreal aflibercept injection in high-risk prethreshold type 1 retinopathy of prematurity. Ophthalmic Res 53(1):15–20

    Article  CAS  PubMed  Google Scholar 

  30. Hard AL, Hellstrom A (2011) On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment—a review. Acta Paediatr 100(12):1523–1527

    Article  PubMed  PubMed Central  Google Scholar 

  31. Martinez-Castellanos MA, Domenzain-Afendulis JL, Hernandez-Rojas ML et al (2007) Safety and efficacy of intravitreal Bevacizumab for retinopathy of prematurity. IOVS 48(13):85

    Google Scholar 

  32. Olguin-Manriquez FJ, Martínez-Castellanos MA. Efectividad de la terapia antiangiogénica intravítrea como adyuvante en la retinopatía del prematuro. Paper presentation. PAAO Meeting 2015 Bogotá, Colombia

  33. Martinez-Castellanos MA, Schwartz S, Hernandez-Rojas ML et al (2013) Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up. Retina 33(2):329–338

    Article  CAS  PubMed  Google Scholar 

  34. Wong RK, Hubschman S, Tsui I (2015) Reactivation of retinopathy of prematurity after ranibizumab treatment. Retina 35(4):675–680

    Article  CAS  PubMed  Google Scholar 

  35. Chen SN, Lian I, Hwang YC et al (2015) Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between Ranibizumab and Bevacizumab. Retina 35(4):667–674

    Article  CAS  PubMed  Google Scholar 

  36. Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML, Salazar-Teran N, Chan RV (2008) Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 28(3 Suppl):S19–S25

    Article  PubMed  Google Scholar 

  37. Nudleman E, Robinson J, Rao P, Drenser KA, Capone A, Trese MT (2015) Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity. Ophthalmology 122(4):755–759

    Article  PubMed  Google Scholar 

  38. Lakhanpal RR, Davis GH, Sun RL, Albini TA, Holz ER (2006) Lens clarity after 3-port lens-sparing vitrectomy in stage 4A and 4B retinal detachments secondary to retinopathy of prematurity. Arch Ophthalmol 124(1):20–23

    Article  PubMed  Google Scholar 

  39. Wu WC, Lai CC, Lin RI et al (2011) Modified 23-gauge vitrectomy system for stage 4 retinopathy of prematurity. Arch Ophthalmol 129(10):1326–1331

    Article  PubMed  Google Scholar 

  40. Carvounis PE, Poll J, Weikert MP, Wilhelmus K, Lakhanpal RR, Holz ER (2010) Refractive outcomes of lens-sparing vitrectomy for retinopathy of prematurity. Arch Ophthalmol 128(7):843–846

    Article  PubMed  Google Scholar 

  41. Kychenthal A, Dorta P (2010) Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity. Retina 30(4 Suppl):S32–S36

    Article  PubMed  Google Scholar 

  42. Kychenthal A, Dorta P (2008) 25-gauge lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Retina 28(3 Suppl):S65–S68

    Article  PubMed  Google Scholar 

  43. El Rayes EN, Vinekar A, Capone A Jr (2008) Three-year anatomic and visual outcomes after vitrectomy for stage 4B retinopathy of prematurity. Retina 28(4):568–572

    Article  PubMed  Google Scholar 

  44. Wu C, Petersen RA, VanderVeen DK (2006) RetCam imaging for retinopathy of prematurity screening. J AAPOS 10(2):107–111

    Article  CAS  PubMed  Google Scholar 

  45. Vinekar A, Gilbert C, Dogra M et al (2014) The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting. Indian J Ophthalmol 62(1):41–49

    Article  PubMed  PubMed Central  Google Scholar 

  46. Ells AL, Holmes JM, Astle WF et al (2003) Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthalmology 110(11):2113–2117

    Article  PubMed  Google Scholar 

  47. Chiang MF, Keenan JD, Starren J et al (2006) Accuracy and reliability of remote retinopathy of prematurity diagnosis. Arch Ophthalmol 124(3):322–327

    Article  PubMed  Google Scholar 

  48. Photographic Screening for Retinopathy of Prematurity Cooperative Group (2008) The photographic screening for retinopathy of prematurity study (photo-ROP). Primary outcomes. Retina 28(3 Suppl):S47–54

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Retina Department, Asociación para Evitar la Ceguera en México, IAP, Vicente Garcia Torres No. 46 Coyoacan, México, DF, Mexico

    Maria A. Martinez-Castellanos

  2. Retina Department, Hospital General Dr. Manuel Gea González, México, DF, Mexico

    Linda A. Cernichiaro-Espinosa, Francisco J. Olguin-Manriquez, Andree Henaine-Berra, Gerardo Garcia-Aguirre & Hugo Quiroz-Mercado

Authors
  1. Linda A. Cernichiaro-Espinosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francisco J. Olguin-Manriquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andree Henaine-Berra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gerardo Garcia-Aguirre
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hugo Quiroz-Mercado
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maria A. Martinez-Castellanos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria A. Martinez-Castellanos.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cernichiaro-Espinosa, L.A., Olguin-Manriquez, F.J., Henaine-Berra, A. et al. New insights in diagnosis and treatment for Retinopathy of Prematurity. Int Ophthalmol 36, 751–760 (2016). https://doi.org/10.1007/s10792-016-0177-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-016-0177-8

Keywords

Search

Navigation